Innovation and Translational Research
We adopt a translational and peer-reviewed approach to our research, ensuring we go from the bench to patient bedside as quickly as possible with innovative technology and treatments.
Artificial Intelligence (AI) and embryo selection
The study will recruit 1,000 patients across our clinics in Australia, Ireland and Denmark and is evaluating the effectiveness of using AI in embryo selection. The AI performs a comprehensive three-dimensional assessment of the growth of embryos through all stages of development and then relates this data to the corresponding pregnancy outcomes. The system has taught itself to identify those embryos with the highest potential of developing a fetal heart, which is a good indicator of the likelihood of a successful pregnancy. The AI then allocates an EmbryoScore; the embryo with the highest score can be selected and transferred.